The solid progress of nanomedicine

João Pedro Martins; José  das Neves; María de la Fuente; Christian Celia; Helena Florindo; Nazende  Günday-Türeli; Amirali Popat; José  Luis Santos; Flávia Sousa; Ruth Schmid; Joy Wolfram; Bruno Sarmento; Hélder A. Santos

doi:10.1007/s13346-020-00743-2

The solid progress of nanomedicine

João Pedro Martins, José das Neves, María de la Fuente, Christian Celia, Helena Florindo, Nazende Günday-Türeli, Amirali Popat, José Luis Santos, Flávia Sousa, Ruth Schmid, Joy Wolfram, Bruno Sarmento, Hélder A. Santos

Research output: Contribution to journal › Article › Scientific › peer-review

Abstract

This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.

Original language	English
Journal	Drug Delivery and Translational Research
Volume	10
Issue number	3
Pages (from-to)	726–729
Number of pages	4
ISSN	2190-393X
DOIs	https://doi.org/10.1007/s13346-020-00743-2
Publication status	Published - Jun 2020
MoE publication type	A1 Journal article-refereed

Fields of Science

CANCER
CHEMOTHERAPY
Cancer therapy
Clinical translation
Nanomedicine
Nanotechnology
PACLITAXEL
Reproducibility
THERAPY
TUMOR
3122 Cancers
221 Nano-technology
317 Pharmacy

Access to Document

10.1007/s13346-020-00743-2

The solid progress of nanomedicineFinal published version, 252 KBLicence: CC BY

Cite this

Martins, João Pedro ; das Neves, José ; de la Fuente, María ; Celia, Christian ; Florindo, Helena ; Günday-Türeli, Nazende ; Popat, Amirali ; Luis Santos, José ; Sousa, Flávia ; Schmid, Ruth ; Wolfram, Joy ; Sarmento, Bruno ; Santos, Hélder A. / The solid progress of nanomedicine. In: Drug Delivery and Translational Research. 2020 ; Vol. 10, No. 3. pp. 726–729.

@article{99ae4920aa5948ce8485619e56c8430b,

title = "The solid progress of nanomedicine",

abstract = "This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.",

keywords = "CANCER, CHEMOTHERAPY, Cancer therapy, Clinical translation, Nanomedicine, Nanotechnology, PACLITAXEL, Reproducibility, THERAPY, TUMOR, 3122 Cancers, 221 Nano-technology, 317 Pharmacy",

author = "Martins, {Jo{\~a}o Pedro} and {das Neves}, Jos{\'e} and {de la Fuente}, Mar{\'i}a and Christian Celia and Helena Florindo and Nazende G{\"u}nday-T{\"u}reli and Amirali Popat and {Luis Santos}, Jos{\'e} and Fl{\'a}via Sousa and Ruth Schmid and Joy Wolfram and Bruno Sarmento and Santos, {H{\'e}lder A.}",

year = "2020",

month = jun,

doi = "10.1007/s13346-020-00743-2",

language = "English",

volume = "10",

pages = "726–729",

journal = "Drug Delivery and Translational Research",

issn = "2190-393X",

publisher = "Springer-Verlag",

number = "3",

}

The solid progress of nanomedicine. / Martins, João Pedro; das Neves, José ; de la Fuente, María; Celia, Christian; Florindo, Helena; Günday-Türeli, Nazende ; Popat, Amirali; Luis Santos, José ; Sousa, Flávia; Schmid, Ruth; Wolfram, Joy; Sarmento, Bruno; Santos, Hélder A.

In: Drug Delivery and Translational Research, Vol. 10, No. 3, 06.2020, p. 726–729.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - The solid progress of nanomedicine

AU - Martins, João Pedro

AU - das Neves, José

AU - de la Fuente, María

AU - Celia, Christian

AU - Florindo, Helena

AU - Günday-Türeli, Nazende

AU - Popat, Amirali

AU - Luis Santos, José

AU - Sousa, Flávia

AU - Schmid, Ruth

AU - Wolfram, Joy

AU - Sarmento, Bruno

AU - Santos, Hélder A.

PY - 2020/6

Y1 - 2020/6

N2 - This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.

AB - This commentary article conveys the views of the board of the Nanomedicine and Nanoscale Delivery Focus Group of the Controlled Release Society regarding the decision of the United States National Cancer Institute (NCI) in halting funding for the Centers of Cancer Nanotechnology Excellence (CCNEs), and the subsequent editorial articles that broadened this discussion.

KW - CANCER

KW - CHEMOTHERAPY

KW - Cancer therapy

KW - Clinical translation

KW - Nanomedicine

KW - Nanotechnology

KW - PACLITAXEL

KW - Reproducibility

KW - THERAPY

KW - TUMOR

KW - 3122 Cancers

KW - 221 Nano-technology

KW - 317 Pharmacy

U2 - 10.1007/s13346-020-00743-2

DO - 10.1007/s13346-020-00743-2

M3 - Article

VL - 10

SP - 726

EP - 729

JO - Drug Delivery and Translational Research

JF - Drug Delivery and Translational Research

SN - 2190-393X

IS - 3

ER -